10th Annual Neonatal Pharmacology Conference 2010

More information on 10th Annual Neonatal Pharmacology Conference

As we offer our vulnerable patients the best, most contemporary care possible, we need to keep in mind that many pharmacologic therapies have not been thoroughly examined in newborns and risk-benefit ratios are not well established. Although new and complex therapeutic interventions bring potential benefits, they can also create new, often unanticipated, complications.